Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CVX vs MRNA✓SelectedUSD · MRNACVX vs MRNA performance historyLatest closeAs of+0.91%11/20
Stock and ETF performance explorer

CVX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+10.8%
MRNA return
+323.5%
Excess return
-312.8%
Maximum drawdown
-13.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.9%-2.2%+3.1%+0.9%
7D-4.5%-12.7%+8.2%-4.5%
30D-7.4%-20.7%+13.3%-7.4%
3M+2.1%+46.3%-44.2%+2.2%
6M+10.8%+305.2%-294.5%+15.1%
All+10.8%+323.5%-312.8%+15.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling